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Abstract: Tanzania launched its first National Action Plan (NAP) on antimicrobial resistance (AMR)
in 2017 to reduce the burden of AMR in the country and contribute to the global response. We aimed
to analyze the implementation of the NAP on AMR in Tanzania using the governance framework.
In-depth interviews were conducted with human and animal health practitioners and national-level
policy actors. We adapted Chua’s AMR governance framework to analyze the development and im-
plementation of the NAP in Tanzania. Implementation of the NAP has realized several achievements,
including: (i) the establishment of a functioning Multi-Sectoral Coordinating Committee for coordi-
nating the implementation of AMR activities; (ii) existence of governance structure; (iii) establishment
of human and animal surveillance sites; (iv) creation of AMR awareness in the community and (v)
availability of guidelines at the health facility level to ensure AMR stewardship. However, some
dimensions of the governance areas, including reporting and feedback mechanisms, accountability,
transparency and sustainability of AMR plans, are not effectively implemented. Addressing these
challenges should involve strengthening the collaboration of the different sectors involved at differ-
ent NAP implementation levels by careful planning and coordination, and provision of adequate
resources to ensure sustainability.
Keywords: antibiotics; antimicrobial resistance; implementation plan; governance; Tanzania
1. Introduction
Antimicrobial resistance (AMR) is a global public health threat. Several studies have
reported the causes of rising AMR, including self-medication [1,2], antibiotic overuse [3],
clinicians’ over-prescription, a strong belief by the public in antibiotics, including non-
prescription purchases [4], veterinary antibiotic use for prophylaxis and growth promo-
tion [5] and inadequate knowledge on Infection prevention and control (IPC) and antimi-
crobial use and limited access to veterinary and extension services, paving the way for
self-treatment and opportunism by profit-driven non-professional veterinary drug sellers
and weak veterinary laws [6]. Furthermore, inappropriate antibiotic use, inadequate dosing
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and incomplete doses are some of the human malpractices that have contributed to the
emergence and spread of antibiotic resistance [7]. It is projected that by 2030, AMR could
force up to 24 million people into extreme poverty [8]. AMR disproportionally affects
low-and middle-income countries (LMICs), characterized by relatively weak health sys-
tems [9], which are often without adequate effective tools for the prevention and treatment
of drug-resistant infections [10]. Most of these countries have limited access to existing
and new quality-assured antimicrobials. Recognizing this threat and in response to the
Agenda of the 68th World Health Assembly (WHA) in May 2015, Tanzania launched its
National Action Plan (NAP) on Antimicrobial Resistance 2017–2022 [11], to tackle AMR
using a one health approach. This five-year plan outlines five key strategic objectives to
address AMR. The development of the NAP was coordinated by the Ministry of Health,
Community Development, Gender, Elderly and Children (herein after referred to as Min-
istry of Health, MoH) in collaboration with the Ministry of Livestock and Fisheries and
the World Health Organization (WHO). Despite the fact that the NAP has been in place
for more than three years, AMR is still a challenge for human, animal and environmental
health in Tanzania [6,12,13].
In several LMICs, including Tanzania, implementation of NAPs for AMR remains
fragmented and lacks comprehensive multi-sectoral and multi-pronged approaches [14].
Moreover, interventions, such as those focusing on improving public health systems and
increasing access to clean water and sanitation, tend to focus disproportionately on urban
geographies [15]. These constraints indicate that AMR is one of the most persistent public
health challenges that requires a domestic governance framework to guide successful
implementation of NAPs [14]. This study analyzed the implementation of the NAP in
Tanzania using the governance framework to provide guidance and recommendations.
Specifically, we used the framework to examine: (i) who was involved in developing the
plan; (ii) what are the objectives Tanzania aims to achieve and how; (iii) its implementation
(how are the identified NAP actions/activities implemented); and (iv) how are NAP
activities monitored and evaluated.
Conceptual Framework of Analysis
Despite widespread agreement that tackling AMR domestically can only be achieved
through a strong governance framework, it is not clear how various efforts to implement
the NAP in Tanzania are following the framework. We adapted Chua’s AMR governance
framework to analyze the development and implementation of the NAP for combating
AMR in Tanzania [16]. The framework (Figure 1) consists of five main governance ar-
eas: policy design, implementation tools, monitoring and evaluation, sustainability and
one health engagement. Policy design focuses on general and procedural issues, such as
broad participation in the development process, coordination across sectors and levels
(from sub-national to national), transparency, implications of equity of AMR policies and
accountability and coordination mechanisms on how to achieve NAP objectives. The imple-
mentation tools refer to various interventions for combating AMR, including antimicrobial
stewardship programs, surveillance, infection prevention and control (IPC) measures,
public awareness activities, medicine regulation and education of relevant professionals.
The monitoring and evaluation component consists of reporting and feedback mechanisms,
which allow regular review and evaluation of the NAP and its (cost-)effectiveness. In addi-
tion, this area assesses whether relevant policies and incentives are available to incentivize
research and development of innovative antimicrobials and other potential alternatives.
The sustainability focuses on resource allocation and availability of a budget for implemen-
tation of the NAP. The fifth governance area is one health engagement and is situated at
the center of all governance areas, indicating the importance of the involvement of human,
animal and environmental health sectors (one health approach) in the implementation of
the NAP. As Chua [16] suggests, in this study, we treat one health engagement as a separate
governance area, which is situated at the center of the governance framework (Figure 1)
since it influences all other governance areas.
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Figure 1. Antimicrobial resistance (AMR) governance framework with four areas and 15 domains adapted from
Chua et al., 2021.
2. Results
The analysis of the implementation of the NAP adapted to Chua’s governance frame-
work consists of five main governance areas: policy design, implementation tools, sustain-
ability, monitoring and evaluation and one health engagement. In the next few sections,
we detail our findings according to each governance area.
2.1. Policy Design
The policy design analysis focused on strategic vision, coordination, participation,
accountability and transparency and equity.
2.1.1. Strategic Vision
Strategic vision implies that the NAP contains clearly defined goals and objectives to
direct interventions. The Tanzania NAP identifies ten priority actions and specific inter-
ventions for each activity with quantifiable targets [11]. The five strategic objectives are to
create awareness and understanding of AMR through effective information, education and
communication, which has two priority actions (awareness raising and risk communication
and education); to strengthen the knowledge and evidence base through surveillance and
research with three priority actions (surveillance system, laboratory capacity and research
and development) and to reduce the incidence of infection through effective sanitation,
hygiene and infection prevention measures with two priority actions (infection prevention
and control in healthcare and health waste management systems). Other strategic objec-
tives are to optimize the use of antimicrobial agents in human and animal health, which has
two priority actions (regulatory framework for preservation of antimicrobial agents and
antimicrobial stewardship programs); and to develop the economic case for sustainable
investment that takes account of the needs of all countries and to increase investment in
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new medicines, diagnostic tools, vaccines and other interventions, which has one priority
action of ensuring sustainability of antimicrobial resistance interventions [11].
2.1.2. Coordination
In Tanzania, the Ministry of Health is the central coordinating ministry, while the
Multi-Sectoral Coordinating Committee (MCC) is responsible for coordinating, facilitating
and overseeing the implementation of all AMR activities. According to the Tanzania
national AMR surveillance framework [17], the implementation of the NAP operations
shall be managed by different ministries and institutions but monitored through the MCC
whose main role is to advise, receive and approve surveillance plans and reports. The
MCC is also responsible for overseeing, coordinating and evaluating all AMR surveillance-
related activities in the food and agriculture sectors, mobilizing required resources and
convening scientific meetings and seminars [17].
2.1.3. Participation
The reviewed literature and interviewees indicate that with the exception of com-
munity members, who were not involved, all other key stakeholders were involved in
the development of the NAP. These included ministries responsible for public health
and animal health, universities and research institutions, regulatory authorities (Tanzania
Medicines and Medical Devices), government agencies (Tanzania Veterinary Laboratory
Agency, National Health Laboratory Quality Assurance and Training Centre); international
organizations (WHO, Food and Agriculture Organization of the United Nations); profes-
sional councils (Pharmacy Council, Veterinary Council of Tanzania), representatives of
health facilities (Muhimbili National Hospital and District Medical Officer) and the private
sector (Pharmaceutical Wholesalers Association) [11].
Interviewees had varying views on the involvement of different sectors in the prepa-
ration of the AMR NAP. Some reported that key sectors like public health, livestock and
fisheries were involved. They stated that because every key sector was involved, it was
easy to outline their roles in the implementation of the plan.
Another respondent claimed that all sectors had equal influence during the prepara-
tion of the NAP:
“I think all sectors were influential because each sector is directly involved and each sector
has advantages in the action plan because we have seen that the issue of bacteria resistance
doesn’t concern one sector, it affects all sectors”. (Key Informant (KI): scientist from
National Laboratory).
Several interviewees raised concerns that not all sectors were involved in the prepara-
tion of the NAP. The environmental sector was not represented despite the fact that waste
management is a substantial concern within the NAP. The health sector was reported as the
dominant sector throughout the development process and was given priority compared to
other sectors.
“Of course, when you talk about these issues involving more than one sector, the human
health sector has often been taking a big part (okay) . . . , even in the plan it took a big
part but at the end of the day it has to touch other sectors because they provide a response
to human health. Human health is leading because it is a priority”. (KI: MoH official)
Most of the key informants said categorically that community members, who are key
in the implementation of the AMR NAP as consumers of antimicrobials, were not included
in preparing the plan.
“There was no direct community involvement but the government prepared action plan.
After the plan is ready the community will be informed and the community will be
educated on what the plan is all about”. (KI: a scientist from the National Laboratory)
Another respondent said:
“I’m not sure about the community involvement. In the sessions which I attended I did
not see a participant specifically from the community”. (KI: MoH official)
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2.1.4. Accountability and Transparency
To ensure accountability and transparency within the NAP, a clear governance structure
under the supervision of MCC has been established [11]. The NAP has a clear budget and
sources of funding for each identified activity for the 5-year plan and this information is in
the public domain as the NAP document is available online. To ensure the overall goal of
combating AMR is met, the MoH developed the National AMR Surveillance Framework [17],
which provides guidelines on how different AMR surveillance sites should provide quarterly
progress reports to various administrative units. However, the interviewees suggest that infor-
mation about resources such as funding to support the implementation of AMR interventions,
including surveillance, is not always publicly available.
Facility-level respondents reported that during their weekly clinical meetings, they
get feedback about drug resistance.
“The guidelines have helped to us observe drug resistance among patients, . . . we get
information through weekly reports, daily reports and monthly reports”. (KI: health
center respondent, Ilala)
2.1.5. Equity
According to the NAP, the Medicines and Therapeutic Committee (MTC) in each
health facility is mandated to ensure the rational use of medicines, including antimicrobials.
The MTCs should monitor prescribing practices to ensure they adhere to the standard treat-
ment, and ensure the availability of up-to-date important reference materials for medicine
information including the Standard Treatment Guidelines and Essential Medicines List [11].
Health facility interviewees reported that every clinician is supposed to have the treatment
guidelines when delivering health services to patients.
“What I know is that every clinician must have guidelines that he/she uses to provide
treatment to patients, guidelines for all the diseases. So, when the clinician finds that a
patient has used a certain medicine for a long time without getting better, then he moves
a patient to another medicine which is stronger”. (KI: health facility in-charge, Ilala)
Regarding equal access to medicines, including antimicrobials, interviewed health
workers reported that the facility management attempts to ensure that all medicines
required are available to all patients who need them.
“So, we came up with a strategy that a pharmacist should make sure we have all the
required medicines. When there is shortage, we should take immediate actions to get
alternative medicines for our patients”. (KI: health worker, Ilala)
Tanzania also has the Standard Treatment Guidelines and National Essential Medicines
List, which reflect the policy of the government of ensuring the availability of safe and
efficacious essential medicines to all its citizens. This is a tool used to promote access
to essential medicines to achieve maximum therapeutic benefit and optimize patient
outcomes [18].
2.2. Implementation Tools
The NAP outlines six dimensions of interventions, which are understood as tools
for implementation. These are surveillance, antimicrobial stewardship programs, IPC
measures, education, AMR research, public awareness activities and medicine regulation.
The following sections examine each intervention.
2.2.1. Surveillance
The National AMR Surveillance Framework aims at generating evidence on the
burden of AMR among priority pathogens isolated in hospitals from patients. The strategic
objectives of this framework are aligned with the National AMR Action Plan based on
national needs and priorities [17]. The framework provides guidelines on how AMR
surveillance across the human and animal sectors should be conducted.
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Eight and three surveillance sites for humans and animals, respectively, have been
established in Tanzania. These surveillance sites consist of five zonal referral hospitals, one
national hospital and three regional hospitals. The surveillance sites are coordinated by
the National Public Health Laboratory. The Sokoine University of Agriculture and two
Zonal Tanzania Veterinary Laboratory Agency’s centers in Mwanza and Arusha are the
only surveillance sites for animals. The 2020 GLASS reports show that Tanzania did not
submit data on any priority pathogens in 2019 because the country had recently begun
surveillance, with the participation of a few laboratories [19]. This was also highlighted by
several of the policy makers. Through surveillance sites, the emergence and prevalence of
AMR can be detected and monitored and the driving factors for its spread and high-risk
groups can be determined and thereby enable plans for effective AMR interventions [20].
2.2.2. Antimicrobial Stewardship
Policy makers stated that in ensuring that there is responsible use of antimicrobials by
healthcare professionals, and more specifically, selection of the most appropriate antimicro-
bials, duration, dose and route of administration, the MoH has distributed the guidelines to
all health facilities, including dispensaries. The MoH provides education to health workers
through on-the-job training programs. The government has also introduced the guidelines
for Health Training Institutions to impart knowledge on AMR to both the instructors and
students. The idea behind it is to ensure that when students graduate, they know and can
implement these standards and guidelines. One of the key informants stated:
“We have now developed antimicrobial stewardship guidelines which will be released at
any time”. (KI: TMDA official)
2.2.3. Infection Prevention and Control
Infection prevention and control (IPC) across human and animal sectors is one of
the key priorities in the NAP. A number of activities have been identified, including
supportive supervision to all health facilities by quality assurance teams. These also
include facilitating the availability of IPC-related equipment, supplies and guidelines,
establishing a functioning vaccination program for human and animal health and engaging
communities in the implementation of personal hygiene and environmental sanitation [11].
National Laboratory staff reported that a working group is responsible for the supervision
of disease prevention nationally. They visit hospitals to check whether health staff comply
with IPC procedures like hand washing, and the effective use of antimicrobials, as well
as hygiene and environmental sanitation. However, it was not clear to what extent these
working groups are effective in ensuring healthcare workers adhere to IPC procedures.
“We already have a guideline and have begun to distribute it to various regions in
preventing and controlling the infection. We are also conduct sensitization campaigns to
create awareness on personal hygiene”. (KI: Ministry of Health official)
2.2.4. AMR Research
The NAP has prioritized AMR research and development activities, which include en-
gaging relevant stakeholders to identify current gaps in knowledge and potential research
areas, developing national research guidelines on AMR and undertaking research related
to AMR. The literature showed that more research on AMR has been conducted after
introduction of the NAP, indicative of the growing importance of AMR in both academic
and policy arenas. The Tanzania national budget allocates 1% of the country’s GDP to
finance research activities [21]. This level is similar to Kenya, which has a comparable GDP.
However, lack of information regarding how much is allocated to AMR-specific research
is an indication of a lack of clear strategies to achieve the identified AMR objectives and
goals. Moreover, in reviewing AMR articles (published from 2018–2020) none has indicated
receiving financial assistance from the government of Tanzania [6,12,13,22].
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2.2.5. Education and Public Awareness
Interviewees reported that there are ongoing education programs to train Health
Training Institutes’ tutors on guidelines and standards regarding antimicrobial use (AMU)
and AMR so that they can train their students. In turn, students also participate in educating
the community about AMU and AMR:
“Community health education has increased and it is not only from the Ministry but
also from individual and other stakeholders. For example, there are Pharmacy student’s
association collaborating with others people to educate the public about AMR”. (KI:
TMDA official)
Different models have been used to create AMR awareness in the general public.
These include local television and radio programs, and newspaper articles produced by
different media houses. There are also regular trainings to ensure proper understanding
and awareness of AMU and AMR among the media.
“There is a technical working group whose main task is to provide education on AMU and
AMR to the general public and students organizes concerts and symposia and involves
students who go around sensitizing the community on AMR”. (KI: MoH official)
Participants reported that during Antibiotic Awareness Week every November, many
awareness activities are conducted by different stakeholders, including the MoH. When
there are public events such as the Nane Nane (Farmers’ Day) exhibitions, the government
and other stakeholders participate in creating awareness of drug resistance in both animals
and humans.
“Government officials go direct to farmers and livestock keepers to provide education
about antibiotics resistance”. (KI: Ministry of Livestock and Fisheries)
2.2.6. Medicine Regulation
A list of medicines is used at all levels of the healthcare system to ensure appropriate
use of antimicrobials. According to the NAP, Tanzania has legislation for the regulation of
the quality, safety and efficacy of medicines including antimicrobial agents. The Tanzania
Medicine and Medical Devices Authority is responsible for managing all drugs, including
antibiotics, in the country. The interviewed policy makers reported that, although the
medicine regulations may be in place, they may only be partially implemented. One of
the main reasons for low levels of implementation is a lack of capacity within primary
healthcare facilities (dispensaries, health centers and district hospitals). These facilities often
do not have adequate financial and human resources, which results in a lack of diagnostic
tools and laboratory equipment to perform culture and antimicrobial susceptibility testing,
as recommended by the guidelines.
“We expect that no person will be prescribed antibiotics before performing culture and
sensitivity in order to be sure the medication you are prescribing is going to work.
However, we failed because some hospitals are not equipped. I also think district hospitals
do not have the capacity”. (KI: MoH official)
2.3. Monitoring and Evaluation
Monitoring and evaluation is an important governance area in the implementation
of the NAP as it generates evidence to inform policy makers, planners and implementers
whether the implementation of the NAP is effective or not. It also involves dissemination
of information and reports to different stakeholders about the implementation of the NAP.
2.3.1. Reporting
There is an established collaboration between the government of Tanzania and the
WHO, and AMR data are transmitted to the international surveillance system through
WHONET software. While the human health sector reports findings to GLASS on a
monthly basis, interviewees pointed out some difficulties in accessing this information.
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According to the NAP, national-level data ought to be used to inform decision-making
processes, however, the existing limited data on AMR are still a challenge in Tanzania.
2.3.2. Feedback Mechanisms
Interviewees reported that efforts have been made to put in place AMR focal per-
sons for human and animal sectors at the national, zonal, regional and lower levels who
are responsible for conducting supervision of AMU and AMR and provide feedback to
the national-level organizations. The national AMR focal persons have the additional
responsibility of reporting on the prevalence and trends in AMR to GLASS. One of the key
informants stated:
“The national level AMR focal persons do conduct supervision of the lower levels. This
is because, currently, only the zonal levels are functioning. It will take time before the
programme is rolled out nation-wide and to all levels”. (KI: MCC member)
2.3.3. Effectiveness of Monitoring and Evaluation
The effectiveness dimension requires that nations should put in place mechanisms to
monitor and evaluate the effectiveness of various AMR interventions and specific policies.
For instance, nations should strive to measure the effect of AMR on human and animal
health [23]. The AMR NAP has a well-stipulated monitoring and evaluation (M&E) plan
for measuring the effects of interventions. According to the M&E plan, a mid-term review,
which was to be performed after 2 years (2019) to monitor the implementation of the NAP,
was not conducted. The end of term evaluation is planned for 2021. The reviewed literature
did not show evidence of efforts done to evaluate the efficacy or cost-effectiveness of specific
policies or interventions. However, key informants reported that the AMR monitoring
team is planning to conduct a situational analysis, which is expected to provide evidence
regarding the effectiveness of some of the implemented interventions. A lack of M&E limits
the country in learning from AMR implementation experiences and identifying barriers to
progress and formulating workable solutions to strengthen implementation of sustainable
AMR interventions.
2.4. Sustainability
Funding and Resource Allocation
Sustainability of the NAP depends much on the allocation of resources and a dedicated
budget. However, interviewed policy makers reported that the MCC receives funds
from development partners to implement activities identified in the NAP. Most of the
interviewed policy makers raised a concern that the sustainability of AMR interventions is
questionable because the majority of them receive funds from development partners.
“Another challenge is insufficient funds compared to existing activities. And if I look
clearly, I see that this AMR is more of donor funded project than the government so when
donors leave, the situation will be difficult”. (KI: FAO representative to MCC)
2.5. One Health Engagement
In a tripartite approach, the FAO, OIE and WHO emphasize that addressing health
risks at the human–animal–plant–ecosystem interfaces requires strong one health engage-
ment [24]. AMR is the global public health threat that requires one health engagement
whereby different actors and sectors, such as human and veterinary medicine, agriculture,
the environment and consumers, should be involved in the development and implemen-
tation of the AMR NAP. Findings revealed that the development and implementation of
the AMR NAP have involved more human and animal health sectors compared with the
environmental sector, which jeopardizes the future achievement of the AMR NAP’s goals
and objectives.
“The preparation of this plan was coordinated by the Ministry of Health, as I explained
it was the issue of one health so we were together with the Ministry of Livestock and
Fisheries”. (KI: Ministry of Health official)
Antibiotics 2021, 10, 273 9 of 16
3. Discussion
Our study has revealed that the implementation of the AMR NAP has realized several
achievements, including: (i) the establishment of a functioning Multi-Sectoral Coordinating
Committee for coordinating, facilitating and overseeing the implementation of all AMR
activities; (ii) existence of governance structure; (iii) establishment of surveillance sites
for humans and animals; (iv) creation of AMR awareness in the community; and (v)
availability of guidelines at the health facility level to ensure AMR stewardship. The
analysis reveals that some of the dimensions of the governance areas, including reporting
and feedback mechanisms to monitor the NAP progress, accountability, transparency,
resource mobilization for research activities and sustainability of AMR plans, were not
effectively implemented, which poses challenges towards effective implementation of the
NAP. Resolving these challenges requires a systematic governance approach to successfully
achieve the desired goals and objectives.
Tanzania’s AMR NAP 2017–2022 has a strategic vision to provide long-term direction.
This implies that the NAP has clear goals and objectives to provide direction to interven-
tions [11]. The strategic vision and objectives of the AMR NAP in Tanzania are in line with
the WHO global action plan on AMR [25]. In Tanzania, the MCC was identified as a central
organization responsible for coordinating, facilitating and overseeing the implementation
of all AMR activities, including surveillance of AMR, mobilizing resources and M&E of
the plan across sectors. However, the MCC is largely dependent on development partners’
support, which will certainly limit its sustainability [26].
Participation in the development and implementation of the AMR NAP is an impor-
tant dimension, which increases ownership and acceptance of the plan, thus facilitating its
implementation. The study findings reveal mixed results. On one hand, the formulation
of the NAP engaged one health key stakeholders such as health, livestock and fisheries,
although the health sector dominated the process. Unfortunately, the environmental sector,
which is a critical actor, was not involved. It was noted that some of the sectors still work
in silos which implies that there is a weak inter-sectoral collaboration and accountability
system. Other sectors prefer to be accountable to their seniors who are in the same sector
and they are hierarchically accountable to them for other responsibilities, making one
health engagement a challenge, which limits effective implementation of the NAP. Notably,
cross-sectoral coordination is problematic in LMICs because the governance structures and
mechanisms to bridge sectors, not only within government but also with nongovernmental
partners and programs, are fragmented or inflexible [27–29]. This observation has also
been observed in Thailand where, although different stakeholders were involved in the
preparation of the plan, ownership and participation in the implementation have been
reported as inadequate [30]. In Kenya, coordination of AMR NAP implementation was
reported as a challenge since it is difficult to coordinate all activities across key sectors:
animal, human and environmental health [31]. Similarly, in Nepal, a separate multi-sectoral
steering committee representing human and animal health sectors as well as other stake-
holders has been formed to facilitate the coordination of AMR activities between sectors,
provide guidance and advocate for policies [32].
In Tanzania, community members, who are key in the implementation of the AMR
NAP as consumers of antimicrobials, were not included in preparing the NAP but were
involved during the implementation of the plan, especially during awareness creation
campaigns, which aim at informing the community on the effects of AMR. In Tanzania,
different stakeholders participated in a series of community awareness-raising activities
calling for responsible use of antibiotics in humans and animals in order to reduce the
effects of antibiotic resistance. A similar dilemma was revealed in a systematic review of
several European countries that indicated that citizens were expected to be recipients of
awareness activities or education interventions stipulated in the AMR NAP documents,
rather than having an active role in taking proactive measures, including those targeting
the reduction of the need for antibiotics [33].
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We report the existence of frameworks for providing regular reports on AMR surveil-
lance data. However, the findings revealed that in Tanzania, data for funding of AMU/AMR
surveillance are not always publicly available [17], which limits transparency. We noted
that implementation of the NAP is largely donor dependent, and thus, the sustainability of
interventions is questionable.
Our study reveals that despite the existence of standard treatment guidelines and
Medicines and Therapeutic Committees that could have ensured equity in accessing antimi-
crobials, there is no evidence to suggest that the implementation of the NAP is equitable.
Access to qualified service providers, including doctors, laboratory technicians and phar-
macists, may partly limit equitable access to existing essential antimicrobials. In LMICs,
unskilled health workers and limited laboratory facilities have been reported as among the
factors contributing to the unnecessary prescription of antimicrobials, thus increasing the
incidence of AMR [10,34,35].
Our findings highlight a lack of surveillance infrastructure and capability as most of
the health facilities, especially in the rural areas, do not have well-equipped laboratory
facilities with skilled personnel. Thus, laboratory infrastructures need to be strengthened
to extend surveillance sites to more public and private healthcare facilities. Similar issues
arise for AMR surveillance in the animal health sector. These challenges are not unique to
Tanzania, but studies indicate that several African countries face similar obstacles [36,37].
Furthermore, the African region has not developed adequate capacity for AMR surveillance
because many countries lack adequate strategies [37,38].
In Tanzania, IPC is one of the key priorities in the NAP and the government has put in
place IPC-related equipment, supplies and guidelines for the implementation of personal
hygiene and environmental sanitation. However, there are no documented studies showing
the effectiveness of these efforts in Tanzania. Similarly, Ghana has a national policy on
IPC [39], however, the uptake by both tertiary and secondary levels of healthcare facilities
is not optimal [40,41] and in most cases, compliance with hand hygiene recommendations
before and after patient contact has been reported to be low [42]. A recent study has
reported that most (95%) countries in Sub Saharan Africa (SSA) do not have fully functional
Water, Sanitation and Hygiene (WASH) or environmental health standards in place across
all healthcare facilities, with only six countries with an animal IPC program [38].
The reviewed literature demonstrates contrary findings about AMR education and
public awareness in most African countries. Notably, there is little continuing education
on AMU for key stakeholders such as prescribers and livestock keepers, including poultry
farmers [6]. In many cases, irrational prescription practices are also driven by subtle
violation of medical ethics at the expense of economic and professional profiteering [43].
The implementation of different education programs for different stakeholders should be
considered by different AMR NAPs as instrumental in ensuring access to and appropriate
use of effective antimicrobials. As part of Tanzania’s efforts to strengthen the education of
public and animal health professionals, the government engages in activities to raise public
awareness and educate the wider population about the risks of AMR. However, it is still
not clear the extent to which these different AMR awareness creation approaches have been
effective in delivering the messages. Like in Tanzania, Ghana deployed similar approaches,
particularly the use of media in creating AMR and AMU awareness in the general public.
In addition, Ghana used civil society organizations to create awareness on AMU and AMR
in communities, specifically targeting farmers’ groups and their associations [44].
Despite the existence of legislations and a list of medicines and pharmacopoeia books
to ensure the quality, safety and efficacy of medicines and to guide the management of
drugs, we noted weak enforcement of these guidelines and legislations, which has resulted
in mismanagement of antibiotics in Tanzania. This includes the dispensing of antimicrobials
by unauthorized people and their sale in the auction markets like any other commodity [12].
Most LMICs reported having legislation in place, however, issues of counterfeit medicine
were among the main problems caused by factors such as the lack of enforcement of laws
and regulations [38].
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Our findings reveal that the reporting of AMR data in Tanzania is limited as there
are no effective mechanisms that feed information to the various centers responsible for
decision and policy making, hence limiting the monitoring and evaluation of the extent of
AMR. Both GLASS and WHONET were identified as reporting systems used in Tanzania.
A systematic review on AMR in the Central African Region highlighted that there is a
paucity of data because of the poor reporting system, which is partly a result of the limited
and poor surveillance system [45,46]. Tanzania has put in place AMR focal persons to
supervise AMU and AMR and provide feedback to national-level organizations. However,
the extent to which these focal persons at different organizational levels are effective
in conducting supervision and providing feedback to the higher authorities is not clear.
Other studies recommended that, given the absence of an effective reporting and feedback
system, countries need proper audit and feedback systems to help strengthen Antimicrobial
Stewardship (AMS) systems [47].
In Tanzania, the NAP includes a section on monitoring and evaluation to measure
the effectiveness of interventions. The Interagency Coordination Group on AMR reported
that it is difficult for poor countries to put in place a robust and accountable system
for monitoring and evaluating NAPs because many of the countries lack systems and
capacity and where systems are available and functional, changes in political power or in
governance systems at different levels become a threat to their sustainability [27]. Like
M&E, research is mentioned in the NAP as one of the pillars of combating AMR. However,
it is not effectively operationalized. Findings from other studies have also reported that
LMICs often lack adequate capacity to support research and development [48].
This is the first study in Tanzania assessing the implementation of AMR NAPs using a
structured governance framework modified from Chua’s framework (2021) to better adapt
to our study findings. The framework allowed a structured format of analysis of various
dimensions of governance areas, which helped to provide Tanzania’s context-specific
analysis of best practices regarding implementation of the NAP. However, our study has
one limitation. Some important information, such as how many resources are allocated
for carrying out the NAP’s activities, could not be obtained. This further speaks to issues
of transparency and accountability and the lack thereof within the NAP, but also to wider
debates on public policy making.
4. Materials and Methods
4.1. Study Design and Aims
This exploratory qualitative study analyses the implementation of the NAP on AMR
in Tanzania using the governance framework. It involved in-depth interviews with animal
and human health practitioners at a sub-national level and senior officials from human,
animal and environmental sectors at the national level. A review of relevant documents,
including guidelines, policies and national and international AMR reports, was conducted
to complement information generated from primary data sources. The exploratory study
design was considered appropriate for this study because it helped the researchers to
conduct an in-depth exploration of views from different key informants at the facility,
district and national levels.
4.2. Study Settings
Three districts, namely, Ilala, Kibaha and Kilosa were selected for the sub-national-
level actors. Ilala is an urban area, densely populated, with informal housing, transport
infrastructure, dump sites, agriculture, industrial commercial activities, fishing and sand
mining. It is highly polluted by effluents from Msimbazi River tributaries originating from
different sources, leakage of effluent from waste dumps, abattoirs and domestic wastewater
from septic tanks and pit latrines that are used by about 85% of the city population. The
selection of the district was based on the following factors: many different livelihood activ-
ities and environmental contamination by effluents and wastes from different sources [6].
Kibaha is characterized by large- and small-scale poultry and fish farming that is likely to
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involve antimicrobials. Kilosa district has a large population of pastoralists keeping cattle,
sheep and goats, and are known to treat their animals frequently with antimicrobials [12].
4.3. Selection and Recruitment of Study Participants
We used a purposive sampling strategy to draw the key informants from each group
of actors, namely, laboratory technicians, livestock officers, in-charges of health centrers
and dispensaries, pharmaceutical assistants and dispensers in Ilala, Kibaha and Kilosa
districts. We identified key informants (practitioners) through a mapping exercise and
under the guidance of officials from the district and ward/village levels. The policy makers
at the national level were purposely selected from the ministries responsible for human
health, livestock and fisheries, food and agriculture. The other national key informants
included members of the AMR MCC and some from the National Regulatory Authority
and National Health Laboratory Quality Assurance and Training Centre. The national-level
key informants were selected because of their roles in the preparation and supervision of
the implementation of the national action plan for AMR.
4.4. Data Collection, Management and Analysis
We conducted 111 in-depth interviews with key informants from national, district and
health facility levels. Interviews lasted 45 to 90 min and were run by 12 research assistants.
All research assistants were trained according to Guidelines on Ethics for Health Research
in Tanzania [49] and we ensured quality control by conducting regular reviews of collected
data. All interviews were conducted in Kiswahili, transcribed verbatim and translated into
English. We used a thematic data analysis approach, which applies both inductive and
deductive reasoning [50]. Furthermore, two levels of an interpretive approach were used
to analyze data: the first level involved viewing or experiencing the implementation of the
NAP from the subjective perspectives of the study participants and the second level was
to understand the meaning of the participants’ experiences in order to provide a “thick
description” of the implementation of the NAP. All investigators collectively identified
and validated emerging themes across a sample of transcripts before a line-by-line analysis
was conducted using NVivo 12 qualitative data analysis software (QSR International Pty
Ltd. Version 12, 2018). Emerging themes were identified and categorized into the four
governance areas: policy design, implementation tools, sustainability and monitoring and
evaluation. At the national level, a saturation point was reached at the 9th participant,
while at the district and lower level, the saturation point was reached at 9, 36, 32 and 34 at
the national level, in Ilala, Kibaha and Kilosa districts, respectively (Table 1).
Table 1. Category and numbers of key informants.
Participants’ Category National Level Ilala Kibaha Kilosa
Ministry of Health, Community Development, Gender, Elderly and Children 7 - - -
Ministry of Livestock and Fisheries 1 - - -
Implementing Partner (FAO) 1 - - -
Environmental Officer from Ilala Municipality 1 - -
Pharmacist and Pharmaceutical Assistants 4 3 2
Public and Private Health Facility Laboratory Technologists/Technicians 7 8 8
Livestock Field Officers 3 4 5
Agro-vets 4 5 6
In-charges of Health Facilities 9 6 8
Dispensers 8 6 5
Total 9 36 32 34
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4.5. Ethical Considerations
All study participants provided their informed consent for inclusion before they
participated in the study and they were informed about anonymity and confidentiality
issues, and that they could withdraw from the study at any time they wished. The Medical
Research Coordinating Committee of the Tanzania National Institute for Medical Research
approved the protocol (Ref. No. NIMR/HQ/R.8a/Vol IX/3147). The study was conducted
following the principles of the Declaration of Helsinki.
5. Conclusions
This study uses a governance framework to analyze the development and imple-
mentation of Tanzania’s AMR NAP according to three governance areas: policy design,
implementation tools and monitoring and evaluation. The NAP is an important first step
in fighting the increase in the prevalence of AMR in the country. While the NAP outlines
strong objectives, operationalizing and implementing them require careful planning with
attention to detail to ensure Tanzania can achieve its goals. This analysis indicates that de-
spite the availability of the NAP, there are challenges in its implementation. These include
weak AMR surveillance, inadequate resources for plan implementation sustainability and
a lack of funding for research and monitoring the progress. Strengthening the one health
approach involving different NAP implementation levels, combined with careful planning
with adequate allocation of resources, should be given top priority in policy and decision
making for the effective implementation of the NAP.
Author Contributions: Conceptualization: M.I.N.M., L.E.G.M., G.F., C.S., B.Z.K., S.E.M., S.K. and
M.R. Methodology and investigation: M.R., L.E.G.M., G.F., C.S., B.Z.K. and S.K. Supervision of data
collection: C.S. and B.Z.K. Data analysis: G.F. Writing—original draft preparation: G.F. Writing—
review, editing and interpretation of data: G.F., A.D.-B., A.-S.J., M.I.N.M., L.E.G.M., C.S., B.Z.K.,
S.E.M., S.K., E.M., T.G.C. and H.L.-Q. All authors have read and agreed to the published version of
the manuscript.
Funding: This study was funded by a Joint DFID/ESRC/MRC/Welcome Trust Health Systems Foun-
dation, which is administered by the Medical Research Council (MRC) UK. Grant (Ref. MR/S012796/1).
Article processing charges were covered by the World Bank supported Eastern and Southern Africa
Centers of Excellence for Infectious Diseases of Humans and Animals (SACIDS-ACE). Project
Grant P151847.
Institutional Review Board Statement: The protocol and permission to perform this study was ap-
proved by the Medical Research Coordinating Committee of the Tanzania National Institute for Medical
Research. In addition, participants signed written informed consent for participation in the study.
Data Availability Statement: In-depth interview guiding questions used to generate information for
the study are attached.
Acknowledgments: We extend our thanks to the regional and district authorities for their support
and facilitation of the study implementation. We are grateful to all national-level officials and
members of the Multi-Stakeholders Coordination Committee for their enthusiasm and participation
in this study. We acknowledge the support received from our research assistants during the course
of data collection. They were Isolide Massawe, David Kiwera, Fausta Mgaya, Fortunata Nyeringo,
Gilbert Mwageni, Jackson Kisamo, Jesca Michael, John Ng’imba, Joyce Kaswamila, Magao Mhando,
Pendo Mtui and Shoko Kashenge.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or
in the decision to publish the results.




FAO Food and Agriculture Organization
GLASS The Global Antimicrobial Resistance and Use Surveillance System
IPC Infection prevention and control
KI Key informant
NAP-AMR National Action Plan on Antimicrobial Resistance
MCC Multi-Sectoral Coordinating Committee
TMDA Tanzania Medicines and Medical Devices Authority
WASH Water sanitation and hygiene
References
1. Spellberg, B.; Gilbert, D.N. The future of antibiotics and resistance: A tribute to a career of leadership by John Bartlett. Clin. Infect.
Dis. 2014, 59 (Suppl. S2), S71–S75. [CrossRef]
2. Llor, C.; Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther.
Adv. Drug Saf. 2014, 5, 229–241. [CrossRef]
3. Lipsitch, M.; Samore, M.H. Antimicrobial use and antimicrobial resistance: A population perspective. Emerg. Infect. Dis. 2002, 8,
347–354. [CrossRef] [PubMed]
4. McNulty, C.A.M.; Boyle, P.; Nichols, T.; Clappison, P.; Davey, P. The public’s attitudes to and compliance with antibiotics. J.
Antimicrob. Chemother. 2007, 60 (Suppl. S1), 63–68. [CrossRef] [PubMed]
5. Van Boeckel, T.P.; Brower, C.; Gilbert, M.; Grenfell, B.T.; Levin, S.A.; Robinson, T.P.; Teillant, A.; Laxminarayan, R. Global trends in
antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA 2015, 112, 5649–5654. [CrossRef]
6. Kimera, Z.I.; Frumence, G.; Mboera, L.E.G.; Rweyemamu, M.; Mshana, S.E.; Matee, M.I.N. Assessment of drivers of antimicrobial
use and resistance in poultry and domestic pig farming in the Msimbazi river basin in Tanzania. Antibiotics 2020, 9, 838. [CrossRef]
7. Omolase, C.; Adeleke, O.; Afolabi, A.; Ofolabi, O. Self medication amongst general outpatients in a Nigerian community hospital.
Ann. Ibadan Postgrad. Med. 2011, 5, 64–67. [CrossRef] [PubMed]
8. World Bank. Drug-Resistant Infections: A Threat to Our Economic Future. World Bank Rep. 2016, 2, 1–132. Available online:
www.worldbank.org (accessed on 13 July 2020).
9. Tomson, G.; Vlad, I. The need to look at antibiotic resistance from a health systems perspective. Ups. J. Med. Sci. 2014, 119,
117–124. [CrossRef]
10. Pokharel, S.; Raut, S.; Adhikari, B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob. Heal.
2019, 4, 4–6. [CrossRef]
11. United Republic of Tanzania (URT). Tanzania National Antimicrobial Resistance Action Plan; Ministry of Health: Dar es Salaam,
Tanzania, 2017; pp. 1–76.
12. Sindato, C.; Mboera, L.E.G.; Katale, B.Z.; Frumence, G.; Kimera, S.; Clark, T.G.; Legido-Quigley, H.; Mshana, S.E.; Rweyemamu,
M.M.; Matee, M. Knowledge, attitudes and practices regarding antimicrobial use and resistance among communities of Ilala,
Kilosa and Kibaha districts of Tanzania. Antimicrob. Resist. Infect. Control 2020, 9, 1–17. [CrossRef]
13. Manyahi, J.; Kibwana, U.; Mgimba, E.; Majigo, M. Multi-drug resistant bacteria predict mortality in bloodstream infection in a
tertiary setting in Tanzania. PLoS ONE 2020, 15, e0220424. [CrossRef] [PubMed]
14. Kakkar, M.; Chatterjee, P.; Chauhan, A.S.; Grace, D.; Lindahl, J.; Beeche, A.; Jing, F.; Chotinan, S. Antimicrobial resistance in South
East Asia: Time to ask the right questions. Glob. Health Action 2018, 11, 1483637. [CrossRef]
15. The World Bank. Pulling Together to Beat Superbugs Knowledge and Implementation Gaps in Addressing Antimicrobial Resistance; World
Bank: Washington, DC, USA, 2019.
16. Chua, A.Q.; Verma, M.; Hsu, L.Y.; Legido-Quigley, H. An analysis of national action plans on antimicrobial resistance in Southeast
Asia using a governance framework approach. Lancet Reg. Health West. Pac. 2021, 7, 100084. [CrossRef]
17. United Republic of Tanzania. National Antimicrobial Resistance Surveillance Framework; COSTECH: Dar es Salaam, Tanzania, 2018.
18. United Republic of Tanzania. Standard Treatment Guidelines and Essential Medicines List; COSTECH: Dar es Salaam, Tanzania, 2013.
19. World Health Organization (WHO). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report; WHO: Geneva,
Switzerland, 2020.
20. World Health Organization (WHO). Surveillance and Monitoring for Antimicrobial Use and Resistance IACG Discussion Paper 1; WHO:
Geneva, Switzerland, 2018.
21. United Republic of Tanzania. COSTECH Rolling Strategic Plan: 2016/17–2020/2021; COSTECH: Dar es Salaam, Tanzania, 2018.
22. Horumpende, P.G.; Said, S.H.; Mazuguni, F.S.; Antony, M.L.; Kumburu, H.H.; Sonda, T.B.; Mwanziva, C.E.; Mshana, S.E.;
Mmbaga, B.T.; Kajeguka, D.C.; et al. Prevalence, determinants and knowledge of antibacterial self-medication: A cross sectional
study in North-eastern Tanzania. PLoS ONE 2018, 13, e020662. [CrossRef]
23. Anderson, M.; Schulze, K.; Cassini, A.; Plachouras, D.; Mossialos, E. A governance framework for development and assessment
of national action plans on antimicrobial resistance. Lancet Infect. Dis. 2019, 19, e371–e384. [CrossRef]
Antibiotics 2021, 10, 273 15 of 16
24. WHO; FAO; OIE. Antimicrobial Resistance: A Manual for Developing National Action Plans; World Health Organization: Geneva,
Switzerland, 2016.
25. World Health Organization. Global Action Plan on Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2015.
26. Acharya, K.P.; Karki, S.; Shrestha, K.; Kaphle, K. One health approach in Nepal: Scope, opportunities and challenges. One Health
2019, 8, 100101. [CrossRef]
27. World Health Organization (WHO). Meeting the Challenge of Antimicrobial Resistance: From Communication to Collective Action;
IACG Discussion Paper; WHO: Geneva, Switzerland, 2018.
28. Kayunze, K.A.; Kiwara, A.; Lyamuya, E.; Kambarage, D.M.; Rushton, J.; Coker, R.; Kock, R. Practice of one health approaches:
Bridges and barriers in Tanzania. Onderstepoort J. Vet. Res. 2014, 81, 1–8. [CrossRef]
29. Mlozi, M.R.S.; Rumisha, S.F.; Mlacha, T.; Bwana, V.M.; Shayo, E.H.; Mayala, B.K.; Malima, R.C.; Mashoto, K.O.; Mboera, L.E.G.
Challenges and opportunities for implementing an intersectoral approach in malaria control in Tanzania. Tanzan. J. Health Res.
2015, 17, 1–16.
30. Sommanustweechai, A.; Tangcharoensathien, V.; Malathum, K.; Sumpradit, N.; Janejai, N.; Jaroenpoj, S. Implementing national
strategies on antimicrobial resistance in Thailand: Potential challenges and solutions. Public Health 2018, 157, 142–146. [CrossRef]
31. Ecumenical Pharmaceutical Network and ReAct. Moving Beyond Antimicrobial Resistance (AMR) National Action Plans
Development to Implementation. In Proceedings of the Africa Annual Conference, Johannesburg, South Africa, 6 September 2017;
Available online: https://www.reactgroup.org/wp-content/uploads/2017/10/RAN_Conference-2017-Report.pdf (accessed on
20 December 2020).
32. Acharya, K.P.; Subramanya, S.H.; Lopes, B.S. Combatting antimicrobial resistance in Nepal: The need for precision surveillance
programmes and multi-sectoral partnership. JAC Antimicrob. Resist. 2019, 1, 2–3. [CrossRef]
33. Castro-Sánchez, E.; Iwami, M.; Ahmad, R.; Atun, R.; Holmes, A.H. Articulating citizen participation in national anti-microbial
resistance plans: A comparison of European countries. Eur. J. Public Health 2018, 28, 928–934. [CrossRef]
34. Munga, M.A.; Mæstad, O. Measuring inequalities in the distribution of health workers: The case of Tanzania. Hum. Resour. Health
2009, 7, 1–12. [CrossRef]
35. Shemdoe, A.; Mbaruku, G.; Dillip, A.; Bradley, S.; William, J.J.; Wason, D.; Hildon, Z.J.L. Explaining retention of healthcare
workers in Tanzania: Moving on, coming to “look, see and go”, or stay? Hum. Resour. Health 2016, 14, 1–13. [CrossRef]
36. Kariuki, S.; Dougan, G. Antibacterial resistance in sub-Saharan Africa: An underestimated emergency. Ann. N. Y. Acad. Sci. 2014,
1323, 43–55. [CrossRef] [PubMed]
37. Ndihokubwayo, J.B.; Yahaya, A.A.; Desta, A.T.; Ki-Zerbo, G.; Odei, E.A.; Keita, B.; Pana, A.P.; Nkhoma, W. Antimicrobial Resistance
in the African Region: Issues, Challenges and Actions Proposed. Key Determinants for the African Region; WHO Office for Africa:
Brazzaville, Republic of Congo, 2013; Volume 16, pp. 27–30.
38. Elton, L.; Thomason, M.J.; Tembo, J.; Velavan, T.P.; Pallerla, S.R.; Arruda, L.B.; Vairo, F.; Montaldo, C.; Ntoumi, F.; Abdel Hamid,
M.M.; et al. Antimicrobial resistance preparedness in sub-Saharan African countries. Antimicrob. Resist. Infect. Control 2020, 9,
1–11. [CrossRef]
39. Ministry of Health, Ghana. National Policy and Guidelines for Infection Prevention and Control in Health Care Settings; Ministry of
Health: Accra, Ghana, 2015.
40. Yevutsey, S.K.; Buabeng, K.O.; Aikins, M.; Anto, B.P.; Biritwum, R.B.; Frimodt-Møller, N.; Gyansa-Lutterodt, M. Situational
analysis of antibiotic use and resistance in Ghana: Policy and regulation. BMC Public Health 2017, 17, 1–7. [CrossRef] [PubMed]
41. Labi, A.K.; Obeng-Nkrumah, N.; Bjerrum, S.; Aryee, N.A.A.; Ofori-Adjei, Y.A.; Yawson, A.E.; Newman, M.J. Physicians
knowledge, attitudes, and perceptions concerning antibiotic resistance: A survey in a Ghanaian tertiary care hospital. BMC Health
Serv. Res. 2018, 18, 1–12. [CrossRef] [PubMed]
42. Asare, A.; Enweronu-Laryea, C.C.; Newman, M.J. Hand hygiene practices in a neonatal intensive care unit in Ghana. J. Infect. Dev.
Ctries. 2009, 3, 352–356. [PubMed]
43. Basu, S.; Garg, S. Journal of Medical Ethics and History of Medicine Letter Antibiotic prescribing behavior among physicians:
Ethical challenges in resource-poor settings. J. Med. Ethics Hist. Med. 2018, 11, 2–5.
44. Opintan, J.A. Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana’s success
story. Afr. J. Lab. Med. 2018, 7, 1–4. [CrossRef] [PubMed]
45. Njukeng, P.A.; Ako-Arrey, D.E.; Amin, E.T.; Njumkeng, C.; Wirsiy, F.S. Antimicrobial Resistance in the Central African Region: A
Review. J. Environ. Sci. Public Health 2019, 3, 358–378.
46. Mathew, P.; Jaguga, C.; Mpundu, M.; Chandy, S.J. Building knowledge and evidence base on antimicrobial resistance in Africa,
through ‘One Health’ based surveillance. Clin. Epidemiol. Glob. Health 2020, 8, 313–317. [CrossRef]
47. Storr, J.; Twyman, A.; Zingg, W.; Damani, N.; Kilpatrick, C.; Reilly, J.; Price, L.; Egger, M.; Grayson, M.L.; Kelley, E.; et al.
Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations.
Antimicrob. Resist. Infect. Control 2017, 6, 1–18. [CrossRef] [PubMed]
48. Seale, A.C.; Gordon, N.C.; Islam, J.; Peacock, S.J.; Scott, J.A.G. AMR surveillance in low and middle-income settings-A roadmap
for participation in the Global Antimicrobial Surveillance System (GLASS). Wellcome Open Res. 2017, 2, 1–17. [CrossRef] [PubMed]
Antibiotics 2021, 10, 273 16 of 16
49. Tanzania National Health Research Ethics Committee. Guidelines of Ethics for Health Research in Tanzania; Tanzania National Health
Research Ethics Committee: Dar es Salaam, Tanzania, 2009; Volume 2009.
50. Fereday, J.; Muir-Cochrane, E. Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive
coding and theme development. Int. J. Qual. Methods 2006, 5, 80–92. [CrossRef]
